Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis: A tissue doppler echocardiographic analysis

Paolo Pattoneri, Fabiola Sozzi, Giovanna Pelà, Enrico Montanari, Paolo Moruzzi, Alberico Borghetti, Maria Domenica Cappellini

Research output: Contribution to journalArticle

Abstract

Aim: Tissue Doppler echocardiography was investigated for its applicability in detecting subtle myocardial involvement in multiple sclerosis patients receiving a low dose of mitoxantrone. Methods and Results: Twenty Caucasian patients with multiple sclerosis (mean age 43.9 ± 9.3 years, 12 males and 8 females) treated with mitoxantrone (mean cumulative dose 35.4 ± 21.6 mg/m2), were compared to 20 healthy subjects (mean age 45.4 ± 15.3 years, 11 males and 9 females) matched for age and gender. All subjects underwent conventional and Tissue Doppler echocardiography. Patients with heart failure, life-threatening arrhythmias, and other prominent manifestations of heart disease were excluded. No differences were observed in blood pressure, heart rate, and conventional systolic and diastolic echocardiographic parameters. At Tissue Doppler echocardiography, patients with multiple sclerosis showed differences of the systolic mechanic expressed by a significant lower S-wave peak velocity at the lateral site of mitral annulus (11.4 ± 2.5 cm/sec vs. 15.0 ± 4.1 cm/sec, P <0.02). Such S-wave peak velocity significantly correlated with a cumulative dose of mitoxantrone (r = -0.37, P <0.05). Conclusion: Tissue Doppler echocardiography suggests an early involvement of the systolic myocardial function at the low dose of mitoxantrone. Therefore, Tissue Doppler echocardiography may be used as a noninvasive method for monitoring subclinical cardiotoxicity in multiple sclerosis patients receiving mitoxantrone.

Original languageEnglish
Pages (from-to)397-402
Number of pages6
JournalEchocardiography
Volume26
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Mitoxantrone
Doppler Echocardiography
Multiple Sclerosis
Cardiac Arrhythmias
Heart Diseases
Healthy Volunteers
Heart Failure
Heart Rate
Cardiotoxicity
Blood Pressure

Keywords

  • Cardiotoxicity
  • Mitoxantrone
  • Multiple sclerosis
  • Tissue Doppler echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis : A tissue doppler echocardiographic analysis. / Pattoneri, Paolo; Sozzi, Fabiola; Pelà, Giovanna; Montanari, Enrico; Moruzzi, Paolo; Borghetti, Alberico; Cappellini, Maria Domenica.

In: Echocardiography, Vol. 26, No. 4, 04.2009, p. 397-402.

Research output: Contribution to journalArticle

Pattoneri, Paolo ; Sozzi, Fabiola ; Pelà, Giovanna ; Montanari, Enrico ; Moruzzi, Paolo ; Borghetti, Alberico ; Cappellini, Maria Domenica. / Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis : A tissue doppler echocardiographic analysis. In: Echocardiography. 2009 ; Vol. 26, No. 4. pp. 397-402.
@article{d9e733fa5a4a4155894befdb80b81e23,
title = "Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis: A tissue doppler echocardiographic analysis",
abstract = "Aim: Tissue Doppler echocardiography was investigated for its applicability in detecting subtle myocardial involvement in multiple sclerosis patients receiving a low dose of mitoxantrone. Methods and Results: Twenty Caucasian patients with multiple sclerosis (mean age 43.9 ± 9.3 years, 12 males and 8 females) treated with mitoxantrone (mean cumulative dose 35.4 ± 21.6 mg/m2), were compared to 20 healthy subjects (mean age 45.4 ± 15.3 years, 11 males and 9 females) matched for age and gender. All subjects underwent conventional and Tissue Doppler echocardiography. Patients with heart failure, life-threatening arrhythmias, and other prominent manifestations of heart disease were excluded. No differences were observed in blood pressure, heart rate, and conventional systolic and diastolic echocardiographic parameters. At Tissue Doppler echocardiography, patients with multiple sclerosis showed differences of the systolic mechanic expressed by a significant lower S-wave peak velocity at the lateral site of mitral annulus (11.4 ± 2.5 cm/sec vs. 15.0 ± 4.1 cm/sec, P <0.02). Such S-wave peak velocity significantly correlated with a cumulative dose of mitoxantrone (r = -0.37, P <0.05). Conclusion: Tissue Doppler echocardiography suggests an early involvement of the systolic myocardial function at the low dose of mitoxantrone. Therefore, Tissue Doppler echocardiography may be used as a noninvasive method for monitoring subclinical cardiotoxicity in multiple sclerosis patients receiving mitoxantrone.",
keywords = "Cardiotoxicity, Mitoxantrone, Multiple sclerosis, Tissue Doppler echocardiography",
author = "Paolo Pattoneri and Fabiola Sozzi and Giovanna Pel{\`a} and Enrico Montanari and Paolo Moruzzi and Alberico Borghetti and Cappellini, {Maria Domenica}",
year = "2009",
month = "4",
doi = "10.1111/j.1540-8175.2008.00812.x",
language = "English",
volume = "26",
pages = "397--402",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Blackwell Publishing Inc.",
number = "4",

}

TY - JOUR

T1 - Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis

T2 - A tissue doppler echocardiographic analysis

AU - Pattoneri, Paolo

AU - Sozzi, Fabiola

AU - Pelà, Giovanna

AU - Montanari, Enrico

AU - Moruzzi, Paolo

AU - Borghetti, Alberico

AU - Cappellini, Maria Domenica

PY - 2009/4

Y1 - 2009/4

N2 - Aim: Tissue Doppler echocardiography was investigated for its applicability in detecting subtle myocardial involvement in multiple sclerosis patients receiving a low dose of mitoxantrone. Methods and Results: Twenty Caucasian patients with multiple sclerosis (mean age 43.9 ± 9.3 years, 12 males and 8 females) treated with mitoxantrone (mean cumulative dose 35.4 ± 21.6 mg/m2), were compared to 20 healthy subjects (mean age 45.4 ± 15.3 years, 11 males and 9 females) matched for age and gender. All subjects underwent conventional and Tissue Doppler echocardiography. Patients with heart failure, life-threatening arrhythmias, and other prominent manifestations of heart disease were excluded. No differences were observed in blood pressure, heart rate, and conventional systolic and diastolic echocardiographic parameters. At Tissue Doppler echocardiography, patients with multiple sclerosis showed differences of the systolic mechanic expressed by a significant lower S-wave peak velocity at the lateral site of mitral annulus (11.4 ± 2.5 cm/sec vs. 15.0 ± 4.1 cm/sec, P <0.02). Such S-wave peak velocity significantly correlated with a cumulative dose of mitoxantrone (r = -0.37, P <0.05). Conclusion: Tissue Doppler echocardiography suggests an early involvement of the systolic myocardial function at the low dose of mitoxantrone. Therefore, Tissue Doppler echocardiography may be used as a noninvasive method for monitoring subclinical cardiotoxicity in multiple sclerosis patients receiving mitoxantrone.

AB - Aim: Tissue Doppler echocardiography was investigated for its applicability in detecting subtle myocardial involvement in multiple sclerosis patients receiving a low dose of mitoxantrone. Methods and Results: Twenty Caucasian patients with multiple sclerosis (mean age 43.9 ± 9.3 years, 12 males and 8 females) treated with mitoxantrone (mean cumulative dose 35.4 ± 21.6 mg/m2), were compared to 20 healthy subjects (mean age 45.4 ± 15.3 years, 11 males and 9 females) matched for age and gender. All subjects underwent conventional and Tissue Doppler echocardiography. Patients with heart failure, life-threatening arrhythmias, and other prominent manifestations of heart disease were excluded. No differences were observed in blood pressure, heart rate, and conventional systolic and diastolic echocardiographic parameters. At Tissue Doppler echocardiography, patients with multiple sclerosis showed differences of the systolic mechanic expressed by a significant lower S-wave peak velocity at the lateral site of mitral annulus (11.4 ± 2.5 cm/sec vs. 15.0 ± 4.1 cm/sec, P <0.02). Such S-wave peak velocity significantly correlated with a cumulative dose of mitoxantrone (r = -0.37, P <0.05). Conclusion: Tissue Doppler echocardiography suggests an early involvement of the systolic myocardial function at the low dose of mitoxantrone. Therefore, Tissue Doppler echocardiography may be used as a noninvasive method for monitoring subclinical cardiotoxicity in multiple sclerosis patients receiving mitoxantrone.

KW - Cardiotoxicity

KW - Mitoxantrone

KW - Multiple sclerosis

KW - Tissue Doppler echocardiography

UR - http://www.scopus.com/inward/record.url?scp=63849299043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63849299043&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8175.2008.00812.x

DO - 10.1111/j.1540-8175.2008.00812.x

M3 - Article

C2 - 19017314

AN - SCOPUS:63849299043

VL - 26

SP - 397

EP - 402

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 4

ER -